Pharmacy mogul sentenced for fraud, ordered to pay $344M

The co-owner of several compounding pharmacies and pharmaceutical distributors was sentenced Jan. 15 to 18 years in prison for his role in a multimillion-dollar scheme to defraud Tricare and private healthcare benefit programs, according to the Department of Justice

Advertisement

Wade Ashley Walters of Hattiesburg, Miss., was sentenced after pleading guilty to conspiracy to commit healthcare fraud and conspiracy to commit money laundering. 

Between 2012 and 2016, Mr. Walters defrauded health benefit programs by distributing compounded medications that were not medically necessary. He and his co-conspirators adjusted prescription formulas to ensure the highest reimbursement, solicited recruiters to procure prescriptions for high-margin compounded medications and paid kickbacks to clinicians to authorize prescriptions for compounded medications, according to the Justice Department. 

In addition to the prison term, Mr. Walters was ordered to pay $287.7 million in restitution and to forfeit $56.6 million that he derived from the fraud scheme. 

More articles on legal and regulatory issues:
Former Beaumont employees charged in medical device theft scheme
Connecticut hospital faces class action for allegedly reusing insulin pens
DOJ recovers $1.8B from healthcare false claims cases: 4 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.